Exosens Shares Surge Over 3% Leading the SBF 120
The French specialist in night vision and imaging technologies for defense significantly recovers in mid-morning trading. The stock climbs to the top of the broad Paris index, in a modestly advancing Parisian market. The rebound comes after a month of decline that had erased some of the gains accumulated over the past year.
A 3.19% Rebound Puts the Stock Above the MM20
Exosens shares gain 3.19% to €58.15, leading the SBF 120 while the broad index only advances by 0.19%. This movement allows the stock to rise above its MM20 at €57.10 (a gap of +1.84%), a threshold that had been lost in recent weeks. The MM200 at €55.85 also remains below the current price, providing a cushion of 4.12%. However, the MM50 at €59.80 remains above the price, at 2.76%: it continues to be the next milestone to watch to validate a more pronounced recovery.
The RSI at 44 remains in the neutral zone, leaving room before any overbought signal. Despite this rebound, the stock still shows a decline of 3.25% over one month and 11.15% over three months, a reminder of the correction experienced since spring. On the other hand, the performance over a year remains solid, at +41.14%.
A Favorable Defense Context Following the Czech Contract in Late June
This environment generally supports European defense stocks, a segment in which Exosens is positioned through its image intensifier tubes and imaging components. As a reminder, the company secured a multi-year contract with the Czech armed forces at the end of June, involving about 17,000 components deliverable until 2032, the largest order ever placed by Prague in this field. The group also obtained a credit facility of 140 million euros from the European Investment Bank to fund its R&D activities. From a stock trajectory perspective, the reconquest of the MM20 is a first signal; the resistance at €61.90, close to the MM50, remains the next identified threshold.
